Oceania Healthcare (ASX:OCA) - CEO, Brent Pattison
CEO, Brent Pattison
Source: Oceania Healthcare
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Oceania Healthcare (OCA) has closed its non-underwritten, NZ$20 million (roughly A$18.49 million) retail offer oversubscribed
  • The retail offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million)
  • The new shares will be issued at NZ$1.27 (about A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares
  • Settlement of the offer is expected to occur tomorrow
  • Oceania Healthcare shares last traded at $1.21 cents on April 14

Oceania Healthcare (OCA) has closed its non-underwritten retail offer oversubscribed.

Oceania Healthcare is a leading provider of healthcare services in New Zealand.

The NZ$20 million (approximately A$18.49 million) offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million). Scaling and the return of any surplus application amounts will be carried out in accordance with the terms of the retail offer.  

The offer was part of Oceania’s equity raising, under which Oceania also undertook a fully underwritten NZ$80 million (roughly A$74 million) placement of new shares to institutional shareholders in New Zealand, Australia and other jurisdictions.

Under the retail offer, eligible existing shareholders could each subscribe for up to NZ$50,000 (around A$46,220) worth of new Oceania shares. Over 5,000 Oceania shareholders applied under the retail offer, with an average application size of NZ$9,600 (approximately A$8,894).

The new shares will be issued at NZ$1.27 (approximately A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares.

Settlement of the offer is expected to occur tomorrow, with new shares ranking equally in all respects to existing ordinary shares.

Oceania Healthcare shares last traded at $1.21 cents on April 14.

oca by the numbers
More From The Market Online

‘Meaningful reduction’: Avita achieves positive Cohealyx grafting study interim results

Avita Medical has unveiled a significant reduction in mean time to skin grafting in positive interim…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Emyira ramps up national growth strategy with NSW recruitment campaign

Emyira has initiated a significant growth program with a targeted clinical workforce recruitment campaign underway in…

Investors will get interim results from Paradigm’s Phase III study in Q3 of this year

Paradigm Biopharma has officially passed a milestone that gives investors in the company a 'fast-track' path…